Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oxford BioMedica, Boston University, Dana Farber Cancer Institute, Massachusetts General Hospital deal

The parties extended a 1997 agreement under which OXB received exclusive rights to a family

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE